Printer Friendly, PDF & Email

Pharmaceutical company pays $54 million in settlement for FCA violation

On January 6, Teva Pharmaceuticals agreed to pay $54 million to settle allegations that the company violated the False Claims Act[1] and the Anti-Kickback Statute[2] by providing unlawful compensation to physician speakers. The allegations were based on whistleblowers’ claims made in 2013.

This document is only available to members. Please log in or become a member.